Opus Point Partners Management »

Biohaven Pharmaceutical Holding shares owned by Opus Point Partners Management

Quarter-by-quarter ownership of Biohaven Pharmaceutical Holding shares owned by Opus Point Partners Management from 13F filings

Historical chart of Opus Point Partners Management investment in Biohaven Pharmaceutical Holding

Tip: Access up to 7 years of quarterly data

All positions including Biohaven Pharmaceutical Holding held by Opus Point Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven Pharmaceutical Holding by Opus Point Partners Management

Quarter filed Position value Share count Share price at filing
2019-09-30 $453k 11k 41.74
2019-06-30 $475k 11k 43.77
2019-03-31 $559k 11k 51.51

More positions owned by Opus Point Partners Management

iShares NASDAQ Biotechnology Index (IBB)
Direxion Shs Etf Tr sp biotch bl
Mettler-Toledo International (MTD)
Bristol Myers Squibb (BMY)
Seattle Genetics
Illumina (ILMN)
Vertex Pharmaceuticals Incorporated (VRTX)
Ionis Pharmaceuticals (IONS)
Alnylam Pharmaceuticals (ALNY)
Alexion Pharmaceuticals
Qiagen Nv
Spark Therapeutics
Fortress Biotech
Proqr Thrapeutics N V shs euro (PRQR)
Incyte Corporation (INCY)

View all positions for Opus Point Partners Management

Top funds holding Biohaven Pharmaceutical Holding

Knoll Capital Management
Birchview Capital
Brevan Howard Capital Management
Itau Unibanco Holding

View all funds holding Biohaven Pharmaceutical Holding